Sort
23,748 grants matching “melanoma”
Oral Cancer Detection Methods in a Community Setting
$604,773Taru Kinnunen · Harvard Medical School · RC2 · FY2010 · DE
Multilevel RCT of Rural Community Sun Safety for Young Children in Sports
$604,703Yelena Ping Wu · University Of Utah · R01 · FY2024 · CA
Deconvoluting CAR T cell heterogeneity to engineer durable antitumor protection
$604,627Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
NIA/RRB Confocal Imaging Facility
$604,445Fred Indig · National Institute On Aging · ZIC · FY2010 · AG
Regulators of Cancer Immunotherapy Response
$604,374Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
$604,191Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2025 · ES
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$604,169University Of Wisconsin Madison · U10 · FY2004 · CA
Dissecting the complexity of metastasis with mathematical models and quantitative experiments with in zebrafish
$603,943Joao Xavier · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$603,809Chrystal Mary Paulos · Emory University · R01 · FY2024 · CA
Dendritic Cell Vaccination During Lymphoid Reconstitution
$603,745Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
$603,742Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA
Targeting lentiviruses to infect chosen cells
$603,733Pin Wang · University Of Southern California · R01 · FY2010 · AI
Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of CrohnâÂÂs Disease
$603,706Scott B Snapper · Boston Children'S Hospital · R01 · FY2020 · DK
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
A digital intervention to improve skin self-examination among melanoma survivors
$603,475Sharon L Manne · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Aim 2: Network-level modeling of single-agent and combination therapy
$603,179Peter Karl Sorger · Harvard Medical School · P50 · FY2016 · GM
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells
$603,086Carl D Novina · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Development of novel selective Rac inhibitors for refractory leukemias
$603,034David A Williams · Boston Children'S Hospital · R01 · FY2017 · CA
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms
$603,025Peggy Reynolds · University Of California, San Francisco · R01 · FY2018 · CA
Basic applications for total-body PET in oncology
$603,021Lorenzo Nardo · University Of California At Davis · R01 · FY2022 · CA
A novel preclinical model of spontaneous metastasis
$602,786Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
NCI National Clinical Trials Network-Network Lead Academic Participating Site
$602,729Lawrence E Flaherty · Wayne State University · U10 · FY2015 · CA